Careers / QA MC Administrator – Apprenticeship F/M
QA MC Administrator – Apprenticeship F/M

November 7, 2024
We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.
Careers / QA MC Administrator – Apprenticeship F/M
We are looking for an Quality Assurance Administrator F/M in apprenticeship contract.
The Quality Assurance Software Process Owner is responsible to ensure that all the Computerized Systems used to perform the Quality Management Activities are effective, compliant to the applicable regulation and Median Standards. He is the first point of contact of all the Quality Assurance system users for any issue observed or change assessment. He is also in charge of the consistency and the harmonization of all the activities performed within those tools. Finally he is also highly involved in the monitoring and tracking of KPIs to demonstrate the efficiency of the quality assurance processes.
Main responsibilities
Education :
Bachelor’s Degree (Bac +3) or Master in progress in Quality Management (Quality Assurance & Quality Monitoring)
Experience :1st experience (work-study contract/internship contract) in the field of Quality Management or a similar position in Pharmaceutical field or clinical trials environment is a plus
Additional requirements:
Since 2002, Median Technologies has been expanding the boundaries of the identification, interpretation, analysis and reporting of imaging data in the medical world. Our core activity is to develop advanced imaging software solutions and platforms for clinical drug development in oncology, diagnostic support, and cancer patient care. Our software solutions improve the management of cancer patients by helping to better identify pathologies, develop and select patient-specific therapies (precision medicine).
The company employs a highly-qualified team and leverages its scientific, technical, medical,
and regulatory expertise to develop innovative medical imaging analysis software based on
Artificial Intelligence, cloud computing and big data. We are driven by our core values that
are essential to us. These values define who we are, what we do, the way we do it, and what
we, as Median, aspire to:
• Leading innovation with purpose
• Committing to quality in
all we do
• Supporting our customers in achieving their goals
• Always remembering to
put the patient first
Today, we are a team of more than 220 people spread worldwide in the US, Europe and China. Our company is growing in a fulfilling international and multicultural environment.